Yang, Haojun https://orcid.org/0000-0003-2685-3899
Zingaro, Vincenzo Andrea
Lincoff, James https://orcid.org/0000-0003-3090-1240
Tom, Harrison https://orcid.org/0000-0001-9402-2371
Oikawa, Satoshi https://orcid.org/0000-0002-7696-8128
Oses-Prieto, Juan A. https://orcid.org/0000-0003-4759-2341
Edmondson, Quinn
Seiple, Ian https://orcid.org/0000-0002-8732-1362
Shah, Hardik https://orcid.org/0000-0001-8408-5686
Kajimura, Shingo https://orcid.org/0000-0003-0672-5910
Burlingame, Alma L. https://orcid.org/0000-0002-8403-7307
Grabe, Michael https://orcid.org/0000-0003-3509-5997
Ruggero, Davide https://orcid.org/0000-0002-9444-5865
Article History
Received: 15 April 2023
Accepted: 3 July 2024
First Online: 14 August 2024
Competing interests
: D.R. is a shareholder of eFFECTOR Therapeutics, Inc., and a member of its scientific advisory board. The other authors declare no competing interests.